Objective
A diverse variety of medical or lifestyle conditions lead to a progressive loss of muscle force by functionally impairing myofibril contractility and causing ultimately myofibril loss. Major underlying risk factors of chronic muscle force loss are ageing, inactive lifestyles, and unbalanced nutrition. Together, these factors are predicted to lead to an endemic incidence of muscle weakness both in the developed countries. Clinical research on the mechanisms involved requires a multidisciplinary approach covering aspects of ageing, metabolism, and on the humoral cross-talk of muscle with other key organs including heart, liver, kidney, and lung. To achieve this, six European groups with complementary expertise in inter-organ-cross-talk during stress-induced secondary myopathies will team-up with three leading teams in the U.S. with expertise in myopathy animal models, myofilament proteins and translation of muscle research into therapeutic interventions, and with one team from South Africa with cutting-edge expertise in the regulation of regenerative capacities in muscle.
Importantly, five SMEs will participate in this RISE network that provide expertise in early muscle disease detection, monitoring, and the developing preventive strategies: Their knowledge on muscle disease detection at early stages and their monitoring during interventions will promote translational innovation. To implement innovation and our joint research program, both early stage and advanced researchers will be seconded from the academic nine teams to these five SMEs and vice versa. Thereby, this RISE scheme will establish a long-term collaborative University-SME driven translational innovative research program innovation in our interdisciplinary field of growing socioeconomic medical importance.
Fields of science
Programme(s)
Coordinator
38221 Volos
Greece
See on map
Participants (16)
91002 Evry
See on map
35129 Padova
See on map
Participation ended
1081 HV Amsterdam
See on map
Participation ended
L69 7ZX Liverpool
See on map
431 00 KARDITSA
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
115 23 Athens
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
69151 NECKARGEMUEND
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
22459 HAMBURG
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
69117 Heidelberg
See on map
Participation ended
64625 BENSHEIM
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
78464 Konstanz
See on map
69117 Heidelberg
See on map
68159 Mannheim
See on map
PL6 8BH PLYMOUTH
See on map
PL4 7AG Plymouth Devon
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1081 HV Amsterdam
See on map
Partners (4)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
32611 5500 Gainesville
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
7600 Stellenbosch
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
85297 Gilbert
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
94607 OAKLAND CA
See on map